Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

1,4-disubstituted anthracene antitumor agents

B S Iyengar1, R T Dorr, D S Alberts

  • 1Department of Pharmacology and Toxicology, University of Arizona, Tucson 85721, USA.

Journal of Medicinal Chemistry
|November 26, 1997
PubMed
Summary

The study synthesized 1,4-disubstituted anthracenes and compared their anti-cancer activity to 9,10-isomers. The 1,4-diamide showed higher potency, while other isomers varied, with DNA binding correlating to efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recognizing ancient papyri by a combination of spectroscopic, diffractional and chromatographic analytical tools.

Scientific reports·2017
Same author

Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Promising agents for chemoprevention of skin cancer.

Current oncology (Toronto, Ont.)·2012
Same author

Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study.

Cancer causes & control : CCC·2012
Same author

Global acetylation and methylation changes predict papillary urothelial neoplasia of low malignant potential recurrence: a quantitative analysis.

International journal of immunopathology and pharmacology·2011
Same author

Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study.

Gynecologic oncology·2007

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Cancer Biology

Background:

  • Anthracene derivatives are investigated for their potential anti-cancer properties.
  • Cytotoxicity is influenced by the substitution pattern on the anthracene core.
  • Structure-activity relationships are crucial for developing effective anti-cancer agents.

Purpose of the Study:

  • To synthesize novel 1,4-disubstituted anthracenes.
  • To evaluate and compare the cytotoxicity of 1,4- and 9,10-disubstituted anthracenes against various cancer cell lines.
  • To explore the correlation between DNA binding affinity and anti-cancer potency.

Main Methods:

  • Synthesis of three series of 1,4-disubstituted anthracenes with specific side chains: [[(dimethylamino)ethyl]amino]methyl, N-[(dimethylamino)ethyl]carbamoyl, and carboxaldehyde (4,5-dihydro-1H-imidazol-2-yl)hydrazone.

Related Experiment Videos

  • Cytotoxicity assays using a panel of human cancer cells (myeloma, melanoma, colon, lung) and murine leukemia cells (L1210 sensitive and multidrug-resistant).
  • Measurement of DNA transition melt temperatures to assess DNA binding affinity.

    • Main Results:

    • The 1,4-diamide derivative exhibited greater potency against the tumor cell panel compared to its 9,10-isomer.
    • The 1,4-diamine and 1,4-hydrazone derivatives were less potent than their respective 9,10-isomers.
    • The 1,4-hydrazone showed activity in P388 leukemia mouse models but not in L1210 leukemia.
    • A positive correlation was observed between increased anti-cancer potency and a higher increase in DNA transition melt temperature.

    Conclusions:

    • The substitution position (1,4- vs. 9,10-) significantly impacts the cytotoxic activity of anthracenes.
    • The N-[(dimethylamino)ethyl]carbamoyl side chain at the 1,4-position confers superior anti-cancer activity compared to its 9,10-isomer.
    • DNA binding affinity appears to be a contributing factor to the anti-cancer efficacy of these anthracene compounds.